Hillsdale Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-229,200
| Closed | -$3.45M | – | 655 |
|
|
2024
Q3 | $3.45M | Buy |
229,200
+134,100
| +141% | +$2.02M | 0.27% | 153 |
|
|
2024
Q2 | $2.72M | Sell |
95,100
-50,300
| -35% | -$1.44M | 0.21% | 168 |
|
|
2024
Q1 | $4.25M | Buy |
145,400
+11,400
| +9% | +$333K | 0.34% | 105 |
|
|
2023
Q4 | $4.52M | Buy |
+134,000
| New | +$4.52M | 0.37% | 84 |
|
|
2019
Q4 | – | Sell |
-18,200
| Closed | -$693K | – | 644 |
|
|
2019
Q3 | $693K | Hold |
18,200
| – | – | 0.06% | 280 |
|
|
2019
Q2 | $792K | Buy |
18,200
+3,400
| +23% | +$148K | 0.08% | 238 |
|
|
2019
Q1 | $563K | Buy |
14,800
+4,200
| +40% | +$160K | 0.05% | 269 |
|
|
2018
Q4 | $456K | Buy |
+10,600
| New | +$456K | 0.05% | 256 |
|